The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|October 1, 2019
Headspace platforms and services for CCI testing, oxygen monitoring, and water activity determination
Author(s)LIGHTHOUSE Instruments
LIGHTHOUSE offers solutions for Container Closure Integrity Testing, headspace Oxygen Monitoring, Moisture Determination of dry product, and Microbial Contamination inspection of media vials.
LIGHTHOUSE offers solutions for Container Closure Integrity Testing, headspace Oxygen Monitoring, Moisture Determination of dry product, and Microbial Contamination inspection of media vials. Our solutions are based on rapid non-destructive laser-based headspace analysis, a proven analytical tool for generating statistical process and product data in all stages of the product life cycle. The LIGHTHOUSE offering includes headspace analysis equipment as well as measurement services. The range of application solution activities can cover feasibility studies, analytical process and product studies, method development, method validation protocols, supply of automated or benchtop platforms, and on-site troubleshooting and support.
Contact Details
Company name: LIGHTHOUSE Instruments
Website:
E-mail:
Stand/Booth number: Hall 11, Stand 110C35
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Trending on Pharmaceutical Technology
1
AI Formulation: Regulators Want Data
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
4
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
5